Jason Bassetti
Lawyers

Filters
Seattle Genetics, Inc. $600 Million Equity Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC-registered offering by Seattle Genetics, Inc. of 13,269,230 shares…
Davis Polk Advises Ultra Clean Holdings, Inc. on Its Follow-On Offering
Davis Polk advised Ultra Clean Holdings, Inc. on its SEC-registered follow-on public offering of 4,761,905 shares of common stock for an aggregate price to the public of approximately $100…
Davis Polk Advises KKR on Its Joint Venture and Related Transactions with FS Investments
Davis Polk is advising KKR on its joint venture and related transactions with FS Investments. The transaction contemplates combining the business development company (BDC) businesses of KKR…
Rambus Inc. $172.5 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Rambus Inc. of $172.5 million aggregate principal amount of its 1.375%…
Davis Polk Advises Comcast Corporation and NBCUniversal Media, LLC on Their $5.5 Billion Exchange Offer
Davis Polk advised Comcast Corporation and NBCUniversal Media, LLC in connection with their $5.5 billion exchange offer of new lower-coupon Comcast senior notes for seven series of Comcast…
Davis Polk Advises McKesson Corporation on Its Acquisition of RxCrossroads from CVS Health Corporation
Davis Polk is advising McKesson Corporation on its acquisition of RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health…
Sienna Biopharmaceuticals Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 4,983,333 shares of common stock of Sienna Biopharmaceuticals, Inc., including shares sold pursuant to…
Davis Polk Advises Penumbra, Inc. on Its Follow-On Offering
Davis Polk advised Penumbra, Inc. on its SEC-registered follow-on public offering of 1,495,000 shares of common stock for an aggregate price to the public of approximately $113.62 million…
Davis Polk Advises McKesson Corporation on $1 Billion Notes Offering by Change Healthcare
Davis Polk advised McKesson Corporation in connection with the offering of $1 billion aggregate principal amount of notes issued by Change Healthcare Holdings, LLC and Change Healthcare…
Davis Polk Advises Inkling Systems on Its Series E Equity Financing
Davis Polk advised Inkling Systems, Inc. in connection with its $25 million Series E round of financing led by Sapphire Ventures.
Founded in 2009, Inkling offers a mobile communication…